Anktiva Side Effects

Generic name: nogapendekin alfa inbakicept

Note: This document provides detailed information about Anktiva.

Applies to nogapendekin alfa inbakicept: intravesical solution Side Effects associated with nogapendekin alfa inbakicept. Some dosage forms listed on this page may not apply specifically to the brand name Anktiva.

Applies to nogapendekin alfa inbakicept: intravesical solution.

Side effects include:

The most common (≥15%) adverse reactions, including laboratory test abnormalities, are increased creatinine, dysuria, hematuria, urinary frequency, micturition urgency, urinary tract infection, increased potassium, musculoskeletal pain, chills, pyrexia.

For healthcare professionals

Applies to nogapendekin alfa inbakicept: intravesical solution.

General adverse events

The most common adverse reactions (greater or equal than 15%) were increased creatinine, dysuria, hematuria, urinary frequency, micturition urgency, urinary tract infection, increased potassium, musculoskeletal pain, chills and pyrexia.^[Ref]

Metabolic

• Very common (10% or more): Increased creatinine (76%), increased potassium (18%)^[Ref]

Genitourinary

• Very common (10% or more): Dysuria (32%), hematuria (32%), urinary frequency (27%), micturition urgency (25%), urinary tract infection (24%), bladder irritation (11%)
• Common (1% to 10%): Nocturia^[Ref]

Other

• Very common (10% or more): Chills (15%), pyrexia (15%), fatigue (14%)^[Ref]

Musculoskeletal

• Very common (10% or more): Musculoskeletal pain (17%)^[Ref]

Gastrointestinal

• Very common (10% or more): Nausea (14%)
• Common (1% to 10%): Diarrhea^[Ref]

See also:

Further information

Anktiva side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.

Medical Disclaimer